Screening for Lung Cancer in Subjects With Family History of Lung Cancer

ConditionLung Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age50-75
SponsorThe University of Hong Kong

About this trial

Lung cancer can be detected via screening of high-risk individuals, i.e current or ex-heavy smokers, with low-dose computer tomography (LDCT) of thorax. The National Lung Screening Trial in US and the NELSON trial in Europe demonstrated reduction in lung cancer mortality with LDCT screening for lung cancer. In Hong Kong, however, there is a prominence of female never-smokers with lung cancer. There is no identifiable risk factors for non-smokers with lung cancer except family history of lung cancer. The hypothesis is that lung cancer screening for subjects with family history of lung cancer, can detect early lung cancer.

Eligibility criteria

Qualifiers

Age 50-75, men or women, smokers or non-smokers

Being first degree relatives (Siblings, children, and parents) of lung cancer subjects

Having no known lung cancer before

Disqualifiers

Non-Chinese

Mentally incompetent to give informed consent

Trial design

Treatments tested in this trial

  • Low dose CT thorax
  • Low dose CT thorax

Treatment groups

1,520 Participants
are divided into 2 treatment groups

Sponsors and collaborators

The University of Hong Kong

Lead sponsor

The Queen Elizabeth Hospital

Collaborator

Kwong Wah Hospital

Collaborator

Hong Kong Sanatorium & Hospital

Collaborator